108 lines
No EOL
16 KiB
XML
108 lines
No EOL
16 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
|
|
|
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
|
<!-- AppResources meta begin -->
|
|
<meta name="paf-app-resources" content="" />
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- AppResources meta end -->
|
|
|
|
<!-- TemplateResources meta begin -->
|
|
<meta name="paf_template" content="" />
|
|
|
|
<!-- TemplateResources meta end -->
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-table" /><meta name="ncbi_acc" content="NBK578045" /><meta name="ncbi_domain" content="niceng136er3" /><meta name="ncbi_report" content="objectonly" /><meta name="ncbi_type" content="table" /><meta name="ncbi_objectid" content="ch3.tab9" /><meta name="ncbi_pcid" content="/NBK578045/table/ch3.tab9/?report=objectonly" /><meta name="ncbi_app" content="bookshelf" />
|
|
<!-- Logger end -->
|
|
|
|
<title>Table 9, Summary of risk thresholds for all age groups - Evidence review for initiating treatment - NCBI Bookshelf</title>
|
|
|
|
<!-- AppResources external_resources begin -->
|
|
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
|
|
|
<!-- AppResources external_resources end -->
|
|
|
|
<!-- Page meta begin -->
|
|
<meta name="robots" content="NOINDEX,NOFOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="author" content="National Guideline Centre (UK)" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Table 9, Summary of risk thresholds for all age groups" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute for Health and Care Excellence (NICE)" /><meta name="DC.Contributor" content="National Guideline Centre (UK)" /><meta name="DC.Date" content="2019/08" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK578045/table/ch3.tab9/" /><meta name="bk-non-canon-loc" content="/books/n/niceng136er3/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK578045/table/ch3.tab9/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
|
|
|
<!-- Page meta end -->
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D42E67D73CBD10000000000180014.m_5" />
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
|
<body class="book-table">
|
|
<div class="grid no_max_width">
|
|
<div class="col twelve_col nomargin shadow">
|
|
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
|
<div class="sysmessages">
|
|
<noscript>
|
|
<p class="nojs">
|
|
<strong>Warning:</strong>
|
|
The NCBI web site requires JavaScript to function.
|
|
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
|
</p>
|
|
</noscript>
|
|
</div>
|
|
<!--/.sysmessage-->
|
|
<div class="wrap">
|
|
<div class="page">
|
|
<div class="top">
|
|
|
|
<div class="header">
|
|
|
|
|
|
</div>
|
|
|
|
|
|
|
|
<!--<component id="Page" label="headcontent"/>-->
|
|
|
|
</div>
|
|
<div class="content">
|
|
<!-- site messages -->
|
|
<div class="container content">
|
|
<div class="object">
|
|
|
|
<div class="main-content lit-style"><div class="body-content whole_rhythm"><div id="ch3.tab9" class="table"><h3><span class="label">Table 9</span><span class="title">Summary of risk thresholds for all age groups</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK578045/table/ch3.tab9/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ch3.tab9_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">Age</th><th id="hd_h_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">1) Minimum risk level from QRISK2</th><th id="hd_h_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">2) Risk threshold at which treatment becomes cost effective (from model)</th><th id="hd_h_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">Decision in clinical practice<sup><a class="bk_pop" href="#ch3.tab9_1">(a)</a></sup></th></tr></thead><tbody><tr><th headers="hd_h_ch3.tab9_1_1_1_1" id="hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Male</th><th headers="hd_h_ch3.tab9_1_1_1_2" id="hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_ch3.tab9_1_1_1_3" id="hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_ch3.tab9_1_1_1_4" id="hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.50%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.66%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.00%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.84%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8.50%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.02%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16.40%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9.72%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11.43%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><th headers="hd_h_ch3.tab9_1_1_1_1" id="hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Female</th><th headers="hd_h_ch3.tab9_1_1_1_2" id="hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_ch3.tab9_1_1_1_3" id="hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th headers="hd_h_ch3.tab9_1_1_1_4" id="hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.90%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.66%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat above 1.66% risk</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.30%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.82%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat above 2.82% risk</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.30%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.94%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11.70%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.53%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr><tr><td headers="hd_h_ch3.tab9_1_1_1_1 hd_b_ch3.tab9_1_1_7_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75</td><td headers="hd_h_ch3.tab9_1_1_1_2 hd_b_ch3.tab9_1_1_7_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17.00%</td><td headers="hd_h_ch3.tab9_1_1_1_3 hd_b_ch3.tab9_1_1_7_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8.52%</td><td headers="hd_h_ch3.tab9_1_1_1_4 hd_b_ch3.tab9_1_1_7_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treat all</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>(a)</dt><dd><div id="ch3.tab9_1"><p class="no_margin">Note: if the risk levels the model found were cost effective (column labelled 2) are lower than the minimum risk level (column labelled 1), then it is cost effective to treat everyone at that age, regardless of risk; otherwise, the model result is the lowest cost effective risk level.</p></div></dd></dl></div></div></div></div></div>
|
|
<div class="post-content"><div><p>From: <a href="/books/NBK578045/" target="mainwindow">Evidence review for initiating treatment</a></p><div class="iconblock clearfix ten_col"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/niceng136er3/" target="mainwindow"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-niceng136er3-lrg.png" alt="Cover of Evidence review for initiating treatment" height="100px" width="80px" /></a><div class="icnblk_cntnt"><div><div>Evidence review for initiating treatment: Hypertension in adults: diagnosis and management: Evidence review C.</div><div class="series-statement">NICE Guideline, No. 136.</div><div>National Guideline Centre (UK).</div><div>London: <a href="https://www.nice.org.uk" target="mainwindow" ref="pagearea=content-footer&targetsite=external&targetcat=link&targettype=publisher">National Institute for Health and Care Excellence (NICE)</a>; 2019 Aug.</div></div></div></div><div class="half_rhythm"><a href="/books/about/copyright/" target="mainwindow">Copyright</a> © NICE 2019.</div><p>NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div></div>
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
<div class="bottom">
|
|
|
|
<div id="NCBIFooter_dynamic">
|
|
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
|
<component id="Breadcrumbs" label="helpdesk"/>-->
|
|
|
|
</div>
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
</div>
|
|
</div>
|
|
<!--/.page-->
|
|
</div>
|
|
<!--/.wrap-->
|
|
</div><!-- /.twelve_col -->
|
|
</div>
|
|
<!-- /.grid -->
|
|
|
|
<span class="PAFAppResources"></span>
|
|
|
|
<!-- BESelector tab -->
|
|
|
|
|
|
|
|
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-table&ncbi_acc=NBK578045&ncbi_domain=niceng136er3&ncbi_report=objectonly&ncbi_type=table&ncbi_objectid=ch3.tab9&ncbi_pcid=/NBK578045/table/ch3.tab9/?report=objectonly&ncbi_app=bookshelf" /></noscript>
|
|
|
|
|
|
<!-- usually for JS scripts at page bottom -->
|
|
<!--<component id="PageFixtures" label="styles"></component>-->
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal106 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
|
</html> |